Tag: Biocon
Burkert inaugurates new manufacturing facility in Pune to strengthen its portfolio...
This state-of-the-art facility is a significant addition to Burkert’s global value chain, aimed at meeting the growing demand in the region by producing components and system solutions
Obituary: Bioscience industry pays rich tributes to Ratan Tata
His loss resonates far beyond the corridors of industry, deeply touching the lives of millions he inspired
Biocon Biologics secures market entry for its Bmab 1200 Biosimilar in...
Under the terms of this settlement agreement, Biocon Biologics has resolved patent disputes with Janssen to secure market entry dates in Europe, the UK, Canada, and Japan
Biocon reports 30% revenue increase and ₹660 crore net profit in...
Biocon's Q1FY25 performance sees 117% EBITDA growth and ₹660 crore net profit, powered by strategic partnerships and biosimilar success
Budget 2024: Kiran Mazumdar Shaw welcomes abolishing of angel tax, focus...
Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics called upon the government to consider GST exemption for all cancer drugs to make cancer care more affordable for patients
Biocon Biologics obtains US-FDA approval for biosimilar Aflibercept for Yesafili
A significant milestone for the company marking its entry into ophthalmology, a new therapeutic area in the United States
Biocon’s European partner Zentiva receives approval from UK MHRA for Liraglutide
The company had earlier announced about the approval received from the MHRA for Liraglutide
Eris Lifesciences acquires Biocon Biologics’ India branded formulations business for Rs...
Both the organizations enter into a long- term collaboration to expand patient access in India
Veeda Clinical Research appoints Dr Mahesh Bhalgat as Group CEO
Prior to joining Veeda, Mahesh was the COO for Syngene International (Biocon Group Company), India’s largest CRO & CDMO company
Biocon included in S&P Global Sustainability Yearbook 2024
S&P Global ESG Score at 63; Inducted in Dow Jones Sustainability Emerging Markets Index for 3rd Year in a Row